Hyloris Pharmaceuticals Sa (0AB6)
LSE
Year End December 30 2023 | 2017 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|---|---|
EUR (€) | EUR (€) | EUR (€) | EUR (€) | EUR (€) | EUR (€) | EUR (€) | EUR (€) | |
Total Revenue | 0 | 213k | 91k | 91k | 175k | 3.1M | 2.39M | 4.21M |
Operating Income | 0 | -3.87M | -5.47M | -5.27M | -7.05M | -10.54M | -11.64M | -15.99M |
Pre Tax Income | 0 | -3.78M | -6.06M | -5.78M | -7.14M | -11.28M | -11.9M | -15.38M |
Net Income | 0 | -3.72M | -5.79M | -5.37M | -7.15M | -11.58M | -11.91M | -15.38M |
Preferred Dividends | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Basic Earnings Per Share (EPS) | 0 | -1.267 | -1.713 | -1.207 | -0.277 | -0.448 | -0.425 | -0.549 |
EBIT | 0 | -3.87M | -5.47M | -5.27M | -7.02M | -10.54M | -11.64M | -15.99M |
EBITDA | 0 | -3.8M | -5.38M | -1.97M | -6.46M | -10.41M | -11.44M | -15.65M |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.